@article{8daafadde13748709140fbf1a9df774a,
title = "A Qualitative Study to Characterize the Humanistic Burden of Kabuki Syndrome in the United States and Canada",
abstract = "Introduction: Kabuki syndrome is a rare congenital condition characterized clinically by unique facial features, abnormalities in the skeleton, finger pad abnormalities, and developmental delays, as well as a range of other health issues. Existing research lacks information on the daily burden of living with Kabuki syndrome. Methods: A survey collected caregiver- and patient-reported data about the experience of living with Kabuki syndrome in order to better understand its presentation and effect on patients and their psychosocial well-being. Results: A total of 68 participants (n = 57 caregivers and n = 11 adolescents) were recruited from the USA and Canada. Caregiver survey participants reported developmental delays and lower IQ in individuals with Kabuki syndrome compared to the general population, as well as difficulty with cognitive-related tasks, need for educational accommodations, and difficulty with particular school subjects and with daily tasks. Additionally, participants reported significant emotional, social, and communication-related impacts of Kabuki syndrome. Adolescent data largely corroborated the information collected from caregivers, with the exception of adolescents reporting the emotional and social impacts as occurring less frequently. Conclusions: Kabuki syndrome is a multidimensional disease which has substantial negative effects on physical, mental, emotional, and social aspects of health-related quality of life. This research adds to the limited existing body of literature on the clinical presentation of Kabuki syndrome and provides a novel perspective into the caregiver and adolescent perception of the burden of Kabuki syndrome.",
keywords = "Adolescents, Caregivers, Humanistic burden, Kabuki syndrome, Patient burden, Patient research, Survey",
author = "Christina Theodore-Oklota and Hartman, {Deborah S.} and Hoffman, {Deborah L.} and Bj{\"o}rnsson, {Hans T.}",
note = "Funding Information: No funding was received for this manuscript but Hans T. Bj{\"o}rnsson is supported by a grant from the Louma G. Foundation. Hans T. Bj{\"o}rnsson is also supported by grants from the Icelandic Research Fund (#195835-051, #206806-051) and the Icelandic Technology Development Fund (#2010588-0611). Takeda Pharmaceutical Company funded the journal{\textquoteright}s Rapid Service and Open Access Fees. Funding Information: Christina Theodore-Oklota is employed by Ultragenyx Pharmaceutical Inc. who funded this research. Deborah Hoffman and Deborah Hartman are or were employed by Takeda Pharmaceuticals at the time this research was conducted. Hans T. Bj{\"o}rnsson was a consultant for Millennium Pharmaceuticals at the time of this study. Funding Information: We thank the participants of the study. Rene King, President & Founder, All Things Kabuki Inc. was essential to participant recruitment and the overall success of this study. No funding was received for this manuscript but Hans T. Bj?rnsson is supported by a grant from the Louma G. Foundation. Hans T. Bj?rnsson is also supported by grants from the Icelandic Research Fund (#195835-051, #206806-051) and the Icelandic Technology Development Fund (#2010588-0611). Takeda Pharmaceutical Company funded the journal?s Rapid Service and Open Access Fees. We thank Shayna Egan, Caitlin Pohl, and Christopher Evans from Endpoint Outcomes for writing assistance. Funding for writing assistance was received from Takeda Pharmaceutical Company. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. Christina Theodore-Oklota, Deborah S. Hartman, Deborah L. Hoffman, and Hans T. Bj?rnsson contributed to the conception and design of the work, drafted and revised the work, provided final approval of all versions, and agreed to be accountable for all aspects of the work. Christina Theodore-Oklota is employed by Ultragenyx Pharmaceutical Inc. who funded this research. Deborah Hoffman and Deborah Hartman are or were employed by Takeda Pharmaceuticals at the time this research was conducted. Hans T. Bj?rnsson was a consultant for Millennium Pharmaceuticals at the time of this study. Caregivers were asked to provide consent for participation and parental permission for their adolescent?s participation via an electronic informed consent form and adolescents were asked to provide consent for participation via an electronic assent form. Data pertaining to this research is available upon request. Publisher Copyright: {\textcopyright} 2021, The Author(s).",
year = "2022",
month = jan,
doi = "10.1007/s12325-021-01953-x",
language = "English (US)",
volume = "39",
pages = "619--631",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Health Communications Inc.",
number = "1",
}